Curaleaf Holdings, Inc. (TSX: CURA)
CURA trades on the Toronto Stock Exchange in Life Sciences, headquartered in New York, United States. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Close · October 14, 2026
C$12.18
-2.87% on the day
Market cap (C$)
C$3.4B
TMX list, September 30, 2026
Market cap (US$)
US$2.4B
Mid cap at 1.4263 C$/US$
1-year return
-4.0%
+19.1% year to date
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of September 30, 2026. US$ figures convert C$ at 1.4263 C$ per US$, the Bank of Canada daily rate for October 14, 2026. Close and returns: Yahoo Finance daily closes for CURA.TO, last bar 2026-10-14, computed by Sophia Capital.
Profile
| Field | Value |
|---|---|
| Ticker | CURA on the Toronto Stock Exchange |
| Yahoo symbol | CURA.TO |
| Sector | Life Sciences, Cannabis |
| Headquarters | New York, United States |
| Listed | 2023-12-14 |
| Listing type | Other |
| Shares outstanding | 233,557,527 |
| Also listed on | No interlisting on the TMX list |
| Index membership | S&P/TSX Composite |
| SEC CIK | 0001756770 |
| Website | No company website on record |
Returns
| Window | Return |
|---|---|
| 1 day | -2.9% |
| 1 week | -14.3% |
| 1 month | -13.3% |
| 3 months | -12.2% |
| 6 months | +22.3% |
| Year to date | +19.1% |
| 1 year | -4.0% |
| From 52-week high | -37.4% |
| 52-week range | C$7.92 to C$19.47 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
151 documents in 12 types. Each title links to the document at its source.
Interim financial statements (1)
| Document | Type | Filed |
|---|---|---|
| Quarterly Report on Form 10-Q of Curaleaf Holdings, Inc. for the Three Months Ended March 31, 2026 Period 2026-03-31 | Quarterly report to shareholders (8-K) | 2026-08-06 |
MD&A (7)
| Document | Type | Filed |
|---|---|---|
| Audited Annual Consolidated Financial Statements and notes thereto as of and for the years ended December 31, 2025 and 2024, together with the report… Period 2025-12-31 | MD&A (annual) (40-F) | 2026-02-27 |
| Audited Annual Consolidated Financial Statements and notes thereto as of and for the years ended December 31, 2024 and 2023, together with the report… Period 2024-12-31 | MD&A (annual) (40-F) | 2025-03-04 |
| Unaudited Condensed Interim Consolidated Financial Statements as of March 31, 2026 and December 31, 2025 and for the Three Ended March 31, 2026 and… Period 2026-03-31 | MD&A (interim) (6-K) | 2026-05-06 |
| Unaudited Condensed Interim Consolidated Financial Statements as of September 30, 2025 and December 31, 2024 and for the Three and Nine Months Ended… Period 2025-09-30 | MD&A (interim) (6-K) | 2025-11-06 |
Annual information form (2)
| Document | Type | Filed |
|---|---|---|
| Annual Information Form dated February 26, 2026 Period 2025-12-31 | Annual information form (40-F) | 2026-02-27 |
| Annual Information Form dated March 3, 2025 Period 2024-12-31 | Annual information form (40-F) | 2025-03-04 |
Material change report (1)
| Document | Type | Filed |
|---|---|---|
| Material Change Report | Material change report (6-K) | 2026-06-17 |
News release (51)
| Document | Type | Filed |
|---|---|---|
| Press release dated October 5, 2026, announcing the Notice of Variation, Change and Extension | News release (8-K) | 2026-10-06 |
| Press release dated October 6, 2026 | News release (8-K) | 2026-10-06 |
| Press release dated September 23, 2026 | News release (8-K) | 2026-10-01 |
| Press release dated September 29, 2026 | News release (8-K) | 2026-10-01 |
Management information circular / proxy (7)
| Document | Type | Filed |
|---|---|---|
| Supplement to Management Information Circular | Management information circular (6-K) | 2026-06-17 |
| Management Information Circular | Management information circular (6-K) | 2026-05-18 |
| Management Information Circular | Management information circular (6-K) | 2025-05-19 |
| Notice of Annual General Meeting of the Shareholders | Notice of meeting (6-K) | 2026-05-18 |
Report of voting results (2)
| Document | Type | Filed |
|---|---|---|
| Report of Voting Results | Report of voting results (6-K) | 2026-06-26 |
| Report of Voting Results | Report of voting results (6-K) | 2025-06-16 |
Prospectus (1)
| Document | Type | Filed |
|---|---|---|
| FORM F-10 | Prospectus (short form) (F-10) | 2025-02-05 |
Annual report (3)
| Document | Type | Filed |
|---|---|---|
| 40-F Period 2025-12-31 | Annual report (40-F) (40-F) | 2026-02-27 |
| 40-F Period 2024-12-31 | Annual report (40-F) (40-F) | 2025-03-04 |
| Annual Report on Form 10-K of Curaleaf Holdings, Inc. for the Year Ended December 31, 2025 Period 2025-12-31 | Annual report to shareholders (8-K) | 2026-08-06 |
Quarterly report (1)
| Document | Type | Filed |
|---|---|---|
| 6-K Period 2026-06-30 | Quarterly report (10-Q) (10-Q) | 2026-08-06 |
Certification (30)
| Document | Type | Filed |
|---|---|---|
| CEO Certification of Interim Filings | Certification (52-109F2) (6-K) | 2026-05-06 |
| CFO Certification of Interim Filings | Certification (52-109F2) (6-K) | 2026-05-06 |
| CEO Certification of Interim Filings | Certification (52-109F2) (6-K) | 2025-11-06 |
| CFO Certification of Interim Filings | Certification (52-109F2) (6-K) | 2025-11-06 |
Other (45)
| Document | Type | Filed |
|---|---|---|
| FORM 8-K | Current report (8-K) (8-K) | 2026-10-06 |
| 8-K | Current report (8-K) (8-K) | 2026-10-06 |
| 8-K | Current report (8-K) (8-K) | 2026-10-05 |
| 8-K | Current report (8-K) (8-K) | 2026-10-01 |
Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
Trading: the last notice, on 2026-04-22, was a resumption.
| Notice | Action | Reason | Notice |
|---|---|---|---|
| 2026-04-22 11:56:41 AM ET | Resumption | No reason stated | CIRO notice |
| 2026-04-22 11:51:41 AM ET | Halt | Single Stock Circuit Breaker | CIRO notice |
| 2025-12-18 1:01:13 PM ET | Halt | Single-Stock Circuit Breaker | CIRO notice |
| 2025-12-18 1:06:16 AM ET | Resumption | No reason stated | CIRO notice |
| 2025-11-24 11:17:14 AM ET | Resumption | No reason stated | CIRO notice |
| 2025-11-24 11:12:14 AM ET | Halt | Single Stock Circuit Breaker | CIRO notice |
| 2025-10-15 12:48:46 PM ET | Halt | Single Stock Circuit Breaker | CIRO notice |
| 2025-10-15 12:53:46 AM ET | Resumption | No reason stated | CIRO notice |
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
| Date | Time | Event | Webcast | Source |
|---|---|---|---|---|
| 2026-11-03 | after market close | Q3 2026 earnings release | No webcast link announced | SEC filing |
| 2026-11-03 | 5:00 p.m. ET | Q3 2026 earnings call | Webcast | SEC filing |
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
US private placements (SEC Form D)
| Filed | Securities | Sold | Offered | Filing |
|---|---|---|---|---|
| 2026-03-11 | Debt | US$345.0M | US$345.0M | SEC EDGAR |
| 2025-01-31 | Debt | US$67.0M | Open-ended | SEC EDGAR |
| 2021-12-30 | Debt, Other | US$135.7M | US$135.7M | SEC EDGAR |
| 2019-06-18 | Equity, Security To Be Acquired, Other | US$8.4M | US$8.4M | SEC EDGAR |
| 2019-06-18 | Equity, Security To Be Acquired, Other | US$14.0M | US$14.0M | SEC EDGAR |
Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| BHC | Bausch Health Companies Inc. | TSX | C$3.1B | +1.8% | -1.3% |
| CRON | Cronos Group Inc. | TSX | C$1.7B | 0.0% | +28.4% |
| APTX | Apotex Health Corp. | TSX | C$7.1B | -16.5% | Under a year of closes |
| BLCO | Bausch + Lomb Corporation | TSX | C$8.7B | -6.4% | +13.4% |
| WELL | WELL Health Technologies Corp. | TSX | C$1.2B | -3.3% | -20.2% |
The app has the price chart, every filing, private raises and the full peer set for CURA.
Open in the app